Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …

Background Remdesivir is considered to be a specific drug for treating coronavirus disease
2019. This systematic review aims to evaluate the clinical efficacy and risk of remdesivir …

Several randomized controlled trials (RCTs) were conducted to investigate the effect of
remdesivir for patients with COVID-19, but their results were conflicting. Thus, we conducted …

Objectives We performed a systematic review and network meta-analysis of randomized
controlled trials (RCTs) to provide updated information regarding the clinical efficacy of …

Purpose: To evaluate the safety and efficacy of remdesivir in adult patients with COVID-19.
Methods: PubMed, Embase, Scopus, Web of Science, Cochrane Library, ClinicalTrials. gov …

Background Efficacy and safety of treatments for hospitalized COVID-19 are uncertain. We
systematically reviewed efficacy and safety of remdesivir for the treatment of COVID-19 …

Since December 2019, COVID-19 has spread across the world almost through 2.5 years. As
of 16 June 2022, the cumulative number of confirmed cases of COVID-19 worldwide has …

Importance/Background: During current public health emergency of COVID-19 pandemic,
repurposing of existing antiviral drugs may be an efficient strategy since there is no proven …

Remdesivir is an antiviral agent that has shown broad‐spectrum activity, including against
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Clinical trials investigating …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …